1. Home
  2. GBTG vs BLLN Comparison

GBTG vs BLLN Comparison

Compare GBTG & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Business Travel Group Inc.

GBTG

Global Business Travel Group Inc.

HOLD

Current Price

$9.48

Market Cap

4.9B

Sector

Technology

ML Signal

HOLD

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

HOLD

Current Price

$103.98

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GBTG
BLLN
Founded
2014
2016
Country
United Kingdom
United States
Employees
27000
N/A
Industry
Computer Software: Prepackaged Software
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
4.4B
IPO Year
2020
2025

Fundamental Metrics

Financial Performance
Metric
GBTG
BLLN
Price
$9.48
$103.98
Analyst Decision
Buy
Buy
Analyst Count
6
7
Target Price
$8.92
$126.71
AVG Volume (30 Days)
1.9M
501.7K
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
173.33
103.40
EPS
0.13
0.48
Revenue
$2,718,000,000.00
$305,112,000.00
Revenue This Year
$21.78
$46.29
Revenue Next Year
$4.29
$30.14
P/E Ratio
$72.81
$220.69
Revenue Growth
12.17
99.97
52 Week Low
$4.96
$61.96
52 Week High
$9.56
$150.44

Technical Indicators

Market Signals
Indicator
GBTG
BLLN
Relative Strength Index (RSI) 60.70 51.64
Support Level $9.44 $79.07
Resistance Level $9.52 $108.50
Average True Range (ATR) 0.03 5.12
MACD -0.00 1.77
Stochastic Oscillator 37.50 58.26

Price Performance

Historical Comparison
GBTG
BLLN

About GBTG Global Business Travel Group Inc.

Global Business Travel Group Inc operates as a business-to-business travel platform. It is engaged in providing software and services to manage travel, expenses, and meetings and events for companies of all sizes. The company is engaged in building the marketplace in B2B travel to deliver unrivaled choice, value, and experiences. It also provides business travel solutions, simplified travel management, and business consulting services. Further, The company generates revenue in two ways that involves fees and other revenues relating to processing and servicing travel transactions received from clients and travel suppliers and revenues for the provision of products and professional services not directly related to transactions received from clients, travel suppliers and Network Partners.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: